Journal article
PHASE 3 STUDY OF IBRUTINIB IN COMBINATION WITH VENETOCLAX IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA (MCL)
CS Tam, S Rule, S Le Gouill, U Vitolo, LC Tsao, N Cavazos, DM Beaupre, ML Wang
Hematological Oncology | Wiley | Published : 2017
DOI: 10.1002/hon.2440_4